Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gait Disorders, Neurologic | 7 | 2022 | 86 | 3.800 |
Why?
|
| Parkinson Disease | 9 | 2022 | 272 | 3.180 |
Why?
|
| Parkinsonian Disorders | 4 | 2014 | 43 | 1.640 |
Why?
|
| Torticollis | 5 | 2015 | 15 | 1.590 |
Why?
|
| Cerebellum | 2 | 2021 | 103 | 1.360 |
Why?
|
| Connectome | 2 | 2021 | 92 | 1.340 |
Why?
|
| Motor Cortex | 2 | 2021 | 158 | 1.260 |
Why?
|
| Nerve Net | 2 | 2020 | 181 | 1.190 |
Why?
|
| Dopamine | 3 | 2022 | 474 | 0.890 |
Why?
|
| Antiparkinson Agents | 1 | 2021 | 34 | 0.790 |
Why?
|
| Neurological Rehabilitation | 1 | 2021 | 12 | 0.770 |
Why?
|
| Executive Function | 1 | 2021 | 106 | 0.730 |
Why?
|
| Deep Brain Stimulation | 6 | 2020 | 71 | 0.730 |
Why?
|
| Mesencephalon | 1 | 2020 | 41 | 0.700 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2019 | 4 | 0.690 |
Why?
|
| Essential Tremor | 1 | 2019 | 8 | 0.680 |
Why?
|
| Lewy Body Disease | 2 | 2009 | 9 | 0.640 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 213 | 0.630 |
Why?
|
| Neck Muscles | 2 | 2015 | 6 | 0.600 |
Why?
|
| Dementia | 2 | 2009 | 158 | 0.570 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 415 | 0.560 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2021 | 413 | 0.560 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 81 | 0.450 |
Why?
|
| Aged | 12 | 2021 | 14862 | 0.430 |
Why?
|
| Lameness, Animal | 1 | 2012 | 3 | 0.420 |
Why?
|
| Spinal Curvatures | 1 | 2012 | 2 | 0.420 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2012 | 4 | 0.420 |
Why?
|
| Huntington Disease | 1 | 2010 | 15 | 0.360 |
Why?
|
| Dystonic Disorders | 1 | 2010 | 9 | 0.360 |
Why?
|
| Humans | 22 | 2022 | 68618 | 0.330 |
Why?
|
| Male | 15 | 2022 | 37321 | 0.310 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2021 | 31 | 0.310 |
Why?
|
| Female | 13 | 2021 | 38074 | 0.310 |
Why?
|
| Plaque, Amyloid | 1 | 2008 | 31 | 0.300 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 146 | 0.300 |
Why?
|
| Temporal Lobe | 1 | 2008 | 125 | 0.300 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 191 | 0.290 |
Why?
|
| Middle Aged | 10 | 2021 | 21147 | 0.280 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 4848 | 0.280 |
Why?
|
| Synapses | 1 | 2008 | 222 | 0.260 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2550 | 0.250 |
Why?
|
| Dystonia | 2 | 2014 | 18 | 0.220 |
Why?
|
| Subthalamic Nucleus | 2 | 2020 | 16 | 0.210 |
Why?
|
| Soccer | 1 | 2022 | 13 | 0.210 |
Why?
|
| Football | 1 | 2022 | 25 | 0.210 |
Why?
|
| Electromyography | 2 | 2014 | 184 | 0.210 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2022 | 13 | 0.200 |
Why?
|
| Time and Motion Studies | 1 | 2021 | 16 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2022 | 73 | 0.200 |
Why?
|
| Shoulder Dislocation | 1 | 2021 | 17 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 2223 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2022 | 64 | 0.200 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 150 | 0.180 |
Why?
|
| Gait | 1 | 2022 | 120 | 0.180 |
Why?
|
| Joint Instability | 1 | 2021 | 87 | 0.180 |
Why?
|
| Shoulder Joint | 1 | 2021 | 110 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2021 | 7029 | 0.170 |
Why?
|
| Attention | 1 | 2021 | 225 | 0.170 |
Why?
|
| Exercise Therapy | 1 | 2021 | 183 | 0.170 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 517 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1851 | 0.160 |
Why?
|
| Psychotic Disorders | 2 | 2017 | 157 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 951 | 0.160 |
Why?
|
| Brain Waves | 1 | 2018 | 30 | 0.150 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 66 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 211 | 0.150 |
Why?
|
| Thalamus | 1 | 2018 | 82 | 0.150 |
Why?
|
| Amantadine | 1 | 2017 | 8 | 0.150 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2017 | 12 | 0.150 |
Why?
|
| Catatonia | 1 | 2017 | 20 | 0.140 |
Why?
|
| Dopamine Agents | 1 | 2017 | 56 | 0.140 |
Why?
|
| Delirium | 1 | 2017 | 45 | 0.140 |
Why?
|
| Hindlimb Suspension | 1 | 2016 | 11 | 0.140 |
Why?
|
| Bed Rest | 1 | 2016 | 17 | 0.140 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2018 | 111 | 0.130 |
Why?
|
| Head Movements | 1 | 2015 | 12 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 2 | 2017 | 402 | 0.130 |
Why?
|
| Postural Balance | 1 | 2015 | 93 | 0.120 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 22 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 32 | 0.120 |
Why?
|
| Reward | 1 | 2015 | 201 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 435 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 98 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 160 | 0.110 |
Why?
|
| Macaca | 1 | 2012 | 24 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2012 | 41 | 0.100 |
Why?
|
| Posture | 1 | 2012 | 107 | 0.100 |
Why?
|
| Huntingtin Protein | 1 | 2010 | 5 | 0.090 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2010 | 5 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2022 | 3705 | 0.090 |
Why?
|
| Adult | 4 | 2020 | 21403 | 0.080 |
Why?
|
| Postmortem Changes | 1 | 2008 | 15 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2009 | 64 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 271 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 290 | 0.080 |
Why?
|
| alpha-Synuclein | 1 | 2008 | 28 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 115 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 134 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 201 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1038 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1174 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1140 | 0.060 |
Why?
|
| Hippocampus | 1 | 2008 | 471 | 0.060 |
Why?
|
| Shoulder | 1 | 2021 | 37 | 0.050 |
Why?
|
| Dyskinesias | 1 | 2020 | 8 | 0.050 |
Why?
|
| Seizures | 1 | 2021 | 279 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2011 | 7277 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 2176 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1603 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 98 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Apathy | 1 | 2015 | 28 | 0.030 |
Why?
|
| Neurotoxins | 1 | 2015 | 30 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2015 | 88 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 18 | 0.030 |
Why?
|
| Animals | 1 | 2012 | 20881 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 782 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2015 | 439 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5717 | 0.020 |
Why?
|